rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2006-7-21
|
pubmed:abstractText |
Proliferation of vascular smooth muscle cells (VSMCs) contributes to restenosis after coronary intervention. We have shown previously that increased expression of plasminogen activator inhibitor type 1 (PAI-1) limits VSMC apoptosis. Because apoptosis and proliferation appear to be linked, we sought to determine whether increased PAI-1 would affect VSMC proliferation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1524-4636
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1777-83
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16709941-Adenoviridae,
pubmed-meshheading:16709941-Animals,
pubmed-meshheading:16709941-Aorta,
pubmed-meshheading:16709941-Caspase 8,
pubmed-meshheading:16709941-Caspases,
pubmed-meshheading:16709941-Cell Division,
pubmed-meshheading:16709941-Cell Proliferation,
pubmed-meshheading:16709941-Cell Survival,
pubmed-meshheading:16709941-Cells, Cultured,
pubmed-meshheading:16709941-Enzyme Activation,
pubmed-meshheading:16709941-Extracellular Signal-Regulated MAP Kinases,
pubmed-meshheading:16709941-Mice,
pubmed-meshheading:16709941-Mice, Transgenic,
pubmed-meshheading:16709941-Muscle, Smooth, Vascular,
pubmed-meshheading:16709941-Myocytes, Smooth Muscle,
pubmed-meshheading:16709941-NF-kappa B,
pubmed-meshheading:16709941-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:16709941-Transfection
|
pubmed:year |
2006
|
pubmed:articleTitle |
Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
|
pubmed:affiliation |
Department of Medicine and Cardiovascular Research Institute, University of Vermont, Burlington, USA. ybchen@path.uab.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|